Liposomal phosphatidylserine inhibits tumor cytotoxicity of liver macrophages induced by muramyl dipeptide and lipopolysaccharide
- 1 December 1996
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1285 (2) , 219-228
- https://doi.org/10.1016/s0005-2736(96)00164-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The immunological potential of apoptotic debris produced by tumor cells and during HIV infectionImmunology Letters, 1994
- Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine.The Journal of Experimental Medicine, 1994
- Role of a serum phospholipase A1in the phosphatidylserine‐induced T cell inhibitionFEBS Letters, 1993
- Maintenance of Tumoricidal Activity and Susceptibility to Reactivation of Subpopulations of Rat Liver MacrophagesJournal of Immunotherapy, 1991
- Therapy of Murine Liver Metastases by Administration of MDP Encapsulated in LiposomesSelective Cancer Therapeutics, 1990
- Inhibition of interferon γ-induced macrophage microbicidal activity against Leishmania major by liposomes: Inhibition is dependent upon composition of phospholipid headgroups and fatty acidsInternational Journal of Immunopharmacology, 1989
- Activation of murine kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptideHepatology, 1988
- Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.Journal of Clinical Investigation, 1985
- Extracellular phospholipase A2 mediates inflammatory hyperaemiaNature, 1981
- Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouseInternational Journal of Immunopharmacology, 1979